Zhu H - Search Results

1

The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial.

Hsiehchen D, Beg MS, Kainthla R, Lohrey J, Kazmi SM, Khosama L, Maxwell MC, Kline H, Katz C, Hassan A, Kubota N, Siglinsky E, Pillai AK, Youssoufian H, Mockbee C, Culm K, Uhlik M, Benjamin L, Brekken RA, Ahn C, Singal AG, Zhu H, Hoshida Y, Yopp AC. Hsiehchen D, et al. Among authors: zhu h. Nat Commun. 2024 Mar 11;15(1):2178. doi: 10.1038/s41467-024-46542-y. Nat Commun. 2024. PMID: 38467639 Free PMC article. Clinical Trial.

2

Infiltrative Hepatocellular Carcinoma: Natural History and Comparison with Multifocal, Nodular Hepatocellular Carcinoma.

Yopp AC, Mokdad A, Zhu H, Mansour JC, Balch GC, Choti MA, Singal AG. Yopp AC, et al. Among authors: zhu h. Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1075-82. doi: 10.1245/s10434-015-4786-7. Epub 2015 Aug 6. Ann Surg Oncol. 2015. PMID: 26245845

3

A Variant in PNPLA3 Associated With Fibrosis Progression but not Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection.

Ali M, Yopp A, Gopal P, Beg MS, Zhu H, Lee W, Singal AG. Ali M, et al. Among authors: zhu h. Clin Gastroenterol Hepatol. 2016 Feb;14(2):295-300. doi: 10.1016/j.cgh.2015.08.018. Epub 2015 Aug 21. Clin Gastroenterol Hepatol. 2016. PMID: 26305067

4

Implementation of a Voice Messaging System is Associated With Improved Time-to-Treatment and Overall Survival in Patients With Hepatocellular Carcinoma.

Mokdad A, Browning T, Mansour JC, Zhu H, Singal AG, Yopp AC. Mokdad A, et al. Among authors: zhu h. J Natl Compr Canc Netw. 2016 Jan;14(1):38-46. doi: 10.6004/jnccn.2016.0005. J Natl Compr Canc Netw. 2016. PMID: 26733553

5

Vascular Invasion and Metastasis is Predictive of Outcome in Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma.

Mokdad AA, Singal AG, Marrero JA, Zhu H, Yopp AC. Mokdad AA, et al. Among authors: zhu h. J Natl Compr Canc Netw. 2017 Feb;15(2):197-204. doi: 10.6004/jnccn.2017.0020. J Natl Compr Canc Netw. 2017. PMID: 28188189

6

Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer.

Sun X, Wang SC, Wei Y, Luo X, Jia Y, Li L, Gopal P, Zhu M, Nassour I, Chuang JC, Maples T, Celen C, Nguyen LH, Wu L, Fu S, Li W, Hui L, Tian F, Ji Y, Zhang S, Sorouri M, Hwang TH, Letzig L, James L, Wang Z, Yopp AC, Singal AG, Zhu H. Sun X, et al. Among authors: zhu h, zhu m. Cancer Cell. 2017 Nov 13;32(5):574-589.e6. doi: 10.1016/j.ccell.2017.10.007. Cancer Cell. 2017. PMID: 29136504 Free PMC article.

7

Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration.

Zhang S, Nguyen LH, Zhou K, Tu HC, Sehgal A, Nassour I, Li L, Gopal P, Goodman J, Singal AG, Yopp A, Zhang Y, Siegwart DJ, Zhu H. Zhang S, et al. Among authors: zhu h. Gastroenterology. 2018 Apr;154(5):1421-1434. doi: 10.1053/j.gastro.2017.12.013. Epub 2017 Dec 21. Gastroenterology. 2018. PMID: 29274368 Free PMC article.

8

Mitotic regulators and the SHP2-MAPK pathway promote IR endocytosis and feedback regulation of insulin signaling.

Choi E, Kikuchi S, Gao H, Brodzik K, Nassour I, Yopp A, Singal AG, Zhu H, Yu H. Choi E, et al. Among authors: zhu h. Nat Commun. 2019 Apr 1;10(1):1473. doi: 10.1038/s41467-019-09318-3. Nat Commun. 2019. PMID: 30931927 Free PMC article.

9

Somatic Mutations Increase Hepatic Clonal Fitness and Regeneration in Chronic Liver Disease.

Zhu M, Lu T, Jia Y, Luo X, Gopal P, Li L, Odewole M, Renteria V, Singal AG, Jang Y, Ge K, Wang SC, Sorouri M, Parekh JR, MacConmara MP, Yopp AC, Wang T, Zhu H. Zhu M, et al. Among authors: zhu h. Cell. 2019 Apr 18;177(3):608-621.e12. doi: 10.1016/j.cell.2019.03.026. Epub 2019 Apr 4. Cell. 2019. PMID: 30955891 Free PMC article.

10

Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial.

Mokdad AA, Zhu H, Beg MS, Arriaga Y, Dowell JE, Singal AG, Yopp AC. Mokdad AA, et al. Among authors: zhu h. Target Oncol. 2019 Oct;14(5):541-550. doi: 10.1007/s11523-019-00663-3. Target Oncol. 2019. PMID: 31429027 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28,132 results

Search Page